[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337007-105":59,"doc-detail-337007-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","microrna-1307-3p-contributes-to-breast-cancer-progression-through-prm2","MicroRNA-1307-3p contributes to breast cancer progression through PRM2","","Breast cancer remains the most common cancer among women worldwide despite improvements in screening and treatment. Dysregulated microRNAs (miRNAs) drive carcinogenesis, and miR-1307-3p is reported to be upregulated in breast cancer tumors, although its target genes are not fully defined. This study quantified miR-1307-3p in breast cancer cell lines, assessed the effects of its inhibition on proliferation, migration, invasion, and angiogenesis, and combined target prediction with experimental validation to identify PRM2.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/microrna-1307-3p-contributes-to-breast-cancer-progression-through-prm2/337007/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/microrna-1307-3p-contributes-to-breast-cancer-progression-through-prm2/337007.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this study?","Question",{"text":112,"@type":113},"The study investigates how miR-1307-3p regulates breast cancer proliferation, migration, invasion, and angiogenesis, and identifies potential target genes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were miR-1307-3p levels and functional effects tested?",{"text":117,"@type":113},"Basal miR-1307-3p levels were quantified in breast cancer cell lines using RT-qPCR, and the impact of miR-1307-3p inhibition was evaluated on proliferation, migration, invasion, and angiogenesis.",{"name":119,"@type":110,"acceptedAnswer":120},"What target gene was confirmed for miR-1307-3p?",{"text":121,"@type":113},"Protamine 2 (PRM2) was confirmed as a miR-1307-3p target using Western blot and dual-luciferase reporter assays.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337007,1790151294,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","DOI: 10.1111/1759-7714.15460  \nORIGINA L ARTICLE  \nMicroRNA-1307-3p contributes to breast cancer progression through PRM2  \nJosé Roberto Estupiñan-Jiménez 1  | Valeria Villarreal-García 1 |  \nVianey Gonzalez-Villasana 1 | Pablo E. Vivas-Mejia 2,3 | Jose Manuel Vazquez-Guillen 4  | Patricio Adrin Zapata-Morin 5 | Marienid Flores-Coln 2,3 |  \nClaudia Altamirano-Torres 1 | Ezequiel Viveros-Valdez 6 | Cristina Ivan 7 | Mohammed H. Rashed 8 | Recep Bayraktar 9 | Cristina Rodríguez-Padilla 4 | Gabriel Lopez-Berestein 7 | Diana Resendez-Perez 1  \n1Departmento de Biología Celular y Genética, Facultad de Ciencias Biolgicas, Universidad Autnoma de Nuevo Len, San Nicols de los Garza, Mexico 2Department of Biochemistry, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico  \n3Comprehensive Cancer Center, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico  \n4Laboratorio de Inmunología y Virología, Facultad de Ciencias Biolgicas, Universidad Autnoma de Nuevo Len, San Nicols de los Garza, Mexico  \n5Laboratorio de Micología y Fitopatología, Unidad de Manipulacin Genética, Facultad de Ciencias Biolgicas, Universidad Autnoma de Nuevo Len, San Nicols de los Garza, Mexico  \n6Departamento de Química, Facultad de Ciencias Biolgicas, Universidad Autnoma de Nuevo Len, San Nicols de los Garza, Mexico 7Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA  \n8Clinical Pharmacy Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt  \n9Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA  \nCorrespondence  \nVianey Gonzalez-Villasana and Diana Resendez Perez, Departmento de Biología Celular y Genética, Facultad de Ciencias Biolgicas, Universidad Autnoma de Nuevo Len, San Nicols de los Garza, Mexico.  \n[Email:](Email: vianey.gonzalezvl@uanl.edu.mx and diana)[ vianey.gonzalezvl@uanl.edu.mx](Email: vianey.gonzalezvl@uanl.edu.mx and diana)[ and](Email: vianey.gonzalezvl@uanl.edu.mx and diana)[ diana](Email: vianey.gonzalezvl@uanl.edu.mx and diana). [resendezpr@uanl.edu.mx](resendezpr@uanl.edu.mx)  \nFunding information  \nPrograma Presupuestario F003, CB2017-2018, CONAHCYT, Grant/Award Number: A1-S- 45974; National Institute of General Medical Sciences (NIGMS) Support for Research Excellence (SuRE) Program (R16) grant, Grant/Award Number: 5R16GM145558-02; Institutional seed funds from the University of Puerto Rico Comprehensive Cancer Center; National Institute of General Medical SciencesResearch Training Initiative for Student Enhancement (NIGMS-RISE) Program, Grant/Award Number: R25-GM061838  \nAbstract  \nBackground: Despite advances in screening and therapy, breast cancer (BC) remains the predominant cancer in women globally. Dysregulation of microRNAs (miRNAs) is pivotal in carcinogenesis across various cancers, including BC. Evidence indicates that miR-1307-3p is upregulated in BC tumors, yet its target genes are not fully elucidated. This study aimed to explore how miR-1307-3p regulates BC proliferation, migration, invasion, and angiogenesis and to identify potential target genes.  \nMethods: Basal miR-1307-3p levels were quantified in BC cell lines MDA-MB-231 and MCF-7, as well as MCF-10A using quantitative real-time reverse transcriptionPCR (RT-qPCR) . The impact of miR-1307-3p inhibition on BC cell proliferation, migration, invasion, and angiogenesis was assessed. Nine miRNA-target prediction databases identified potential miR-1307-3p targets. Target expression was validated using RT-qPCR, Western blot, and dual-luciferase reporter assays. MiR-1307-3p was overexpressed in MDA-MB-231 and MCF-7 compared to MCF-10A.  \nResults: Inhibiting miR-1307-3p significantly reduced BC cell proliferation, migration, invasion, and angiogenesis. Bioinformatics analysis identified 17 potential miR- 1307-3p targets, with protamine 2 (PRM2) overexpression confirmed via Western blot and dual-l","cbCaifz2puoNRQAL","https://ap.wps.com/l/cbCaifz2puoNRQAL","pdf",2054686,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Breast cancer burden and treatment needs\n## Role of miRNAs in gene regulation and cancer\n## Prior evidence for miR-1307-3p in breast cancer","[{\"question\":\"What is the main focus of this study?\",\"answer\":\"The study investigates how miR-1307-3p regulates breast cancer proliferation, migration, invasion, and angiogenesis, and identifies potential target genes.\"},{\"question\":\"How were miR-1307-3p levels and functional effects tested?\",\"answer\":\"Basal miR-1307-3p levels were quantified in breast cancer cell lines using RT-qPCR, and the impact of miR-1307-3p inhibition was evaluated on proliferation, migration, invasion, and angiogenesis.\"},{\"question\":\"What target gene was confirmed for miR-1307-3p?\",\"answer\":\"Protamine 2 (PRM2) was confirmed as a miR-1307-3p target using Western blot and dual-luciferase reporter assays.\"}]","MicroRNA-1307-3p contributes to breast cancer progression through PRM2 | PDF",1790017374,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a68569b1cc2daf34bf18a22fad645753.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51de485ef58ce2cb0c4ea49f6c743f89.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffe75e115ee127b0ebc1d54578a3aae3.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db7032b78e891286075c7a70b15edd80.webp",980,1287]